As of January, 31, 2019 PDI is no longer a Publicis Health/Publicis Groupe company. Look for all our new branding soon!

Pharmaceutical Sales Strategies for Psychiatric Care

Psychiatric disorders call for an individualized treatment approach and treatment adherence is key to maintaining good patient outcomes over time.

In psychiatric care, the key to success is in tailoring treatment to individual needs, and managing medication side effects to enable long-term treatment. In a challenging practice environment, where psychiatrists must manage chronic diseases that require patients to be treatment adherent over indefinite periods of time, the lack of patient and caregiver education, potentially irreversible side effects, and formulary restrictions are critical barriers to care. Thus, relapse prevention for conditions like schizophrenia or bipolar disorder, as well as treating other diseases such as depression to full remission are important challenges to clinical practice.

PDI supports sales strategies aimed at overcoming formulary restrictions and maintaining excellent outcomes over time through patient education.

Giving psychiatrists access to the full range of psychiatric medications despite formulary restrictions and promoting treatment adherence are key elements of pharmaceutical sales strategies in psychiatry. Our field based and inside medical sales representatives provide education on pharmacologic treatments. Our managed market work with psychiatrists and payers to give patients access to needed medications that may be subject to formulary restrictions. To promote treatment adherence and optimize patient outcomes, our clinical health educators (CHEs) can educate patients and their families on psychiatric disorders, the effects of psychiatric medications, and side effect management. Where needed, we will deploy medical science liaisons (MSLs) to deliver expert in-depth clinician education on emerging psychiatric treatments.

To optimize outcomes, psychiatrists can benefit from assistance in the following areas:

  • Assistance in overcoming formulary medication restrictions to give individual patients access to medications with better tolerability
  • Patient and caregiver education on the symptoms, prognosis, and importance of adherence to psychiatric treatments
  • Education regarding mechanisms of action as well as adverse effects of emerging psychiatric medications
  • Guidance on switching between treatments to meet the needs of individual patients

Learn how we can help support your target psychiatrists and improve the lives of their patients

Contact Us Now